NEW YORK (Reuters Health) – In patients with chronic coronary artery disease, prasugrel overcomes high on-clopidogrel platelet reactivity more effectively than doubling the dose of clopidogrel, results of…
NEW YORK (Reuters Health) – More intensive blood glucose lowering won’t reduce the risk of heart failure in patients with type 2 diabetes, and when achieved with a…
NEW YORK (Reuters Health) – Thoracoscopic unilateral extended thymectomy (TUET) is “the best treatment option” for patients undergoing surgery for nonthymomatous myasthenia gravis, clinicians from Romania conclude in…
NEW YORK (Reuters Health) – Hospitalized nonsurgical patients (medical patients and those with acute stroke) should receive pharmacologic venous thromboembolism (VTE) prophylaxis, unless the risk for bleeding outweighs…
NEW YORK (Reuters Health) – Older patients with advanced hematologic malignancies and comorbid conditions can successfully undergo nonmyeloablative allogeneic hematopoietic cell transplantation (HCT), results of a new study…
NEW YORK (Reuters Health) – After organ transplantation, the overall risk of any new malignancy doubles, according to a new report from the U.S. National Cancer Institute. The…
NEW YORK (Reuters Health) – All women found to have vulvar intraepithelial neoplasia (VIN) require some form of treatment and follow-up surveillance, according to recommendations from The American…
NEW YORK (Reuters Health) – The institution of lipid-lowering therapy has significantly reduced mortality in patients with homozygous familial hypercholesterolemia (FH), researchers from South Africa report in the…
NEW YORK (Reuters Health) – For women with advanced breast cancer, capecitabine provides similar overall survival with less toxicity compared with classical cyclophosphamide, methotrexate, and fluorouracil (CMF) first-line…
NEW YORK (Reuters Health) – Triamcinolone acetonide injected through the cricothyroid membrane prompts significant improvement in patients with vocal nodules. Almost half of the nodules disappeared within weeks,…